Published in Graefes Arch Clin Exp Ophthalmol on May 10, 2011
En face enhanced depth imaging optical coherence tomography features in adult onset foveomacular vitelliform dystrophy. Graefes Arch Clin Exp Ophthalmol (2013) 0.80
Identification of Drusen Characteristics in Age-Related Macular Degeneration by Polarization-Sensitive Optical Coherence Tomography. Am J Ophthalmol (2015) 0.80
Multimodal imaging of acquired vitelliform lesion diagnosed at pseudohypopyon stage. Case Rep Ophthalmol Med (2013) 0.79
Multimodal morphological and functional characterization of Malattia Leventinese. Graefes Arch Clin Exp Ophthalmol (2012) 0.76
Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol (2004) 5.14
Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. Am J Ophthalmol (2000) 2.27
Adult vitelliform macular detachment occurring in patients with basal laminar drusen. Am J Ophthalmol (1985) 1.96
Drusen as risk factors in age-related macular disease. Am J Ophthalmol (1990) 1.66
Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. Exp Eye Res (2005) 1.50
Relationship of Basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Invest Ophthalmol Vis Sci (2007) 1.44
Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. Invest Ophthalmol Vis Sci (2005) 1.39
Hydrodynamics of ageing Bruch's membrane: implications for macular disease. Exp Eye Res (1996) 1.21
Spectral domain optical coherence tomography characteristics of cuticular drusen. Retina (2009) 1.13
Age-related alterations in the diffusional transport of amino acids across the human Bruch's-choroid complex. J Opt Soc Am A Opt Image Sci Vis (2002) 1.10
Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression. Invest Ophthalmol Vis Sci (2006) 1.04
The effect of age on the macromolecular permeability of human Bruch's membrane. Invest Ophthalmol Vis Sci (2001) 0.97
Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients. Graefes Arch Clin Exp Ophthalmol (1991) 0.93
The influence of path length and matrix components on ageing characteristics of transport between the choroid and the outer retina. Invest Ophthalmol Vis Sci (2004) 0.83
Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med (2006) 20.84
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol (2006) 2.82
Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol (2013) 2.44
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology (2012) 2.32
Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol (2012) 2.28
Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function. Retina (2014) 2.11
WEDGE-SHAPED SUBRETINAL HYPOREFLECTIVITY IN GEOGRAPHIC ATROPHY. Retina (2015) 2.05
Changes in macular function after ozurdex for retinal vein occlusion. Optom Vis Sci (2014) 2.02
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet (2011) 1.98
Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Mol Vis (2005) 1.62
Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Am J Ophthalmol (2002) 1.61
Natural course of adult-onset foveomacular vitelliform dystrophy: a spectral-domain optical coherence tomography analysis. Am J Ophthalmol (2011) 1.60
Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial. Ophthalmology (2013) 1.58
Adult-onset foveomacular vitelliform dystrophy: a study by optical coherence tomography. Am J Ophthalmol (2003) 1.56
Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol (2007) 1.51
Preferential hyperacuity perimeter in best vitelliform macular dystrophy. Retina (2011) 1.41
Choroidal changes associated with reticular pseudodrusen. Invest Ophthalmol Vis Sci (2012) 1.35
Hyperreflective pyramidal structures on optical coherence tomography in geographic atrophy areas. Retina (2014) 1.31
Intravitreal ranibizumab for choroidal neovascularization in angioid streaks. Am J Ophthalmol (2010) 1.30
Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr (2008) 1.29
A prospective study of reticular macular disease. Ophthalmology (2011) 1.22
Choroidal infarction following photodynamic therapy with verteporfin. Arch Ophthalmol (2005) 1.22
Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol (2008) 1.21
Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol (2011) 1.19
ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. Am J Ophthalmol (2010) 1.19
Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3. Hum Mol Genet (2012) 1.18
Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat (2011) 1.17
Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology (2012) 1.16
Visual impairment and quality of life in the older European population, the EUREYE study. Acta Ophthalmol (2009) 1.14
Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Ophthalmologica (2012) 1.13
Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype. Int J Epidemiol (2012) 1.12
Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci (2012) 1.10
Ocular modifications in a young girl with cryopyrin-associated periodic syndromes responding to interleukin-1 receptor antagonist anakinra. J Ophthalmic Inflamm Infect (2011) 1.07
Re: Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration. Retina (2014) 1.07
Correspondence. Retina (2015) 1.06
Macular hole following intravitreal ranibizumab injection for choroidal neovascular membrane caused by age-related macular degeneration. Acta Ophthalmol (2009) 1.06
Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia. Retina (2010) 1.05
Methods for a population-based study of the prevalence of and risk factors for age-related maculopathy and macular degeneration in elderly European populations: the EUREYE study. Ophthalmic Epidemiol (2004) 1.05
Analysis of progression of reticular pseudodrusen by spectral domain-optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 1.05
High-resolution spectral domain optical coherence tomography findings in multifocal vitelliform macular dystrophy. Surv Ophthalmol (2009) 1.04
Genotypic influences on severity of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 1.03
Pathologic insights from integrated imaging of reticular pseudodrusen in age-related macular degeneration. Retina (2011) 1.03
High-definition optical coherence tomography features in vitelliform macular dystrophy. Am J Ophthalmol (2008) 1.03
Regulation of subfoveal choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci (2006) 1.02
TYPE 2 NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION IMAGED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina (2015) 1.01
Optical coherent tomography features of malattia leventinese. Am J Ophthalmol (2006) 1.01
Surgical treatment of subfoveal neovascularization in myopia: macular translocation vs surgical removal. Am J Ophthalmol (2002) 0.99
PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population. Mol Vis (2007) 0.99
Correlation of visual function impairment and optical coherence tomography findings in patients with adult-onset foveomacular vitelliform macular dystrophy. Am J Ophthalmol (2008) 0.98
rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration. PLoS One (2009) 0.97
High-definition optical coherence tomographic visualization of photoreceptor layer and retinal flecks in fundus albipunctatus associated with cone dystrophy. Arch Ophthalmol (2009) 0.97
Multimodal imaging of dry age-related macular degeneration. Acta Ophthalmol (2012) 0.96
Intravitreal ranibizumab for choroidal neovascularization related to traumatic Bruch's membrane rupture. Graefes Arch Clin Exp Ophthalmol (2009) 0.96
Circulating omega-3 Fatty acids and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 0.95
Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol (2003) 0.95
Comparison of macular choroidal thickness in adult onset foveomacular vitelliform dystrophy and age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 0.95
INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up. Retina (2016) 0.94
DNA-based eye colour prediction across Europe with the IrisPlex system. Forensic Sci Int Genet (2011) 0.94
Ranibizumab for exudative age-related macular degeneration: 24-month outcomes from a single-centre institutional setting. Br J Ophthalmol (2009) 0.94
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF SUBRETINAL FIBROSIS IN AGE-RELATED MACULAR DEGENERATION. Retina (2015) 0.93
Genotype-phenotype correlations for exudative age-related macular degeneration associated with homozygous HTRA1 and CFH genotypes. Invest Ophthalmol Vis Sci (2008) 0.93
Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gene. Mol Vis (2009) 0.93
Associations between aspirin use and aging macula disorder: the European Eye Study. Ophthalmology (2011) 0.93
Angiographic and optical coherence tomography characteristics of recent myopic choroidal neovascularization. Am J Ophthalmol (2013) 0.93
Analysis of retinal flecks in fundus flavimaculatus using high-definition spectral-domain optical coherence tomography. Am J Ophthalmol (2010) 0.92
Optical coherence tomography angiography during follow-up: qualitative and quantitative analysis of mixed type I and II choroidal neovascularization after vascular endothelial growth factor trap therapy. Ophthalmic Res (2015) 0.91